ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH – Trademark Portfolio

Entity Type: 03

ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. The owner is based in Munich.

Max Planck Strasse 6

D-85609 Dornach

Munich , DE

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ADATOMED
ADATOMED
Cancelled 1995

Trademark Classifications

ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH have?

ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH has 1 U.S. trademark filed with the USPTO.

What trademark classes does ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH file in?

ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What is ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH's trademark registration success rate?

ADATOMED PHARMAZEUTISCHE UND MEDIZINTECHNISCHE GESSELLSCHAFT MBH has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.